Philip Mazzara Sells 6,801 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 6,801 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

• On Thursday, May 21st, Philip Mazzara sold 796 shares of Astera Labs stock. The shares were sold at an average price of $291.03, for a total value of $231,659.88.

Astera Labs Price Performance

ALAB stock opened at $290.52 on Friday. The company has a market cap of $50.40 billion, a P/E ratio of 143.82 and a beta of 3.84. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock’s fifty day moving average price is $354.34 and its 200-day moving average price is $244.64.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Scorpio growth is becoming the key catalyst: Analysts expect Scorpio to overtake Aries as Astera Labs’ largest product family, increasing the company’s semiconductor content per AI accelerator. Third-quarter revenue guidance implies approximately 40% sequential growth to about $550 million, while operating margins are expected to approach 43%. Astera Labs: Scorpio Is Becoming The Real Story
• Positive Sentiment: AI connectivity demand remains strong: Recent coverage points to record demand for Astera’s data-center connectivity products as hyperscalers and other customers expand AI infrastructure. The company’s latest quarter showed revenue growth of 104.5% year over year to $392.4 million, while EPS exceeded consensus estimates. Astera Labs stock in focus on record AI-connectivity demand
• Positive Sentiment: Analyst sentiment improved: Northland Securities upgraded ALAB to “Outperform.” MarketBeat reports a “Moderate Buy” consensus rating and an average price target of $333, while other analysts have raised targets following the company’s earnings report. Northland Securities Upgrades Astera Labs to Outperform
• Positive Sentiment: Strong relative growth profile: Comparisons with Credo and monday.com emphasize Astera’s accelerating quarterly revenue trajectory and exposure to AI connectivity, though investors should remember these are opinion-based comparisons rather than new company guidance. Credo vs. Astera Labs: Which AI Connectivity Stock Is the Better Buy?
• Neutral Sentiment: Insider sales were tax-related: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares totaling roughly $64 million. The filings state the transactions covered tax withholding from vested equity awards, and each executive retained a substantial position; nevertheless, the sales could weigh on short-term sentiment. SEC insider transaction filing
• Negative Sentiment: Valuation and technical pressure remain risks: Astera trades at a price-to-earnings ratio above 140 and below its 50-day moving average. With a beta near 3.8, the stock is particularly sensitive to profit-taking and shifts in AI-sector sentiment after its sharp prior rally.

Institutional Investors Weigh In On Astera Labs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Astera Labs in the second quarter worth $6,609,581,000. Atreides Management LP increased its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. State Street Corp raised its position in shares of Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after purchasing an additional 760,358 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after purchasing an additional 104,935 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on ALAB shares. Roth Capital reaffirmed a “buy” rating and set a $450.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Royal Bank Of Canada raised their price objective on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. Susquehanna boosted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Needham & Company LLC upped their target price on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Barclays lifted their price target on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.